Total Payments
$8,003
2024 Payments
$1,156
Companies
29
Transactions
442
Medicare Patients
835
Medicare Billing
$62,081
Payment Breakdown by Category
Food & Beverage$7,975 (99.6%)
Education$28.03 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,975 | 440 | 99.6% |
| Education | $28.03 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,124 | 129 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,681 | 107 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $681.19 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $630.85 | 38 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $261.04 | 4 | $0 (2024) |
| GENZYME CORPORATION | $258.65 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $240.88 | 11 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $214.96 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $211.95 | 11 | $0 (2024) |
| QOL Medical, LLC | $193.20 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,156 | 50 | Phathom Pharmaceuticals, Inc. ($242.74) |
| 2023 | $2,369 | 130 | ABBVIE INC. ($588.59) |
| 2022 | $2,190 | 131 | ABBVIE INC. ($624.59) |
| 2021 | $2,289 | 131 | AbbVie Inc. ($731.25) |
All Payment Transactions
442 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $113.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Obesity | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Gastroenterology | ||||||
| 04/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Obesity | ||||||
| 04/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Gastroenterology | ||||||
| 04/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Gastroenterology | ||||||
| 04/10/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Immunology | ||||||
| 03/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.19 | General |
| 03/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Gastroenterology | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CNS | ||||||
| 03/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Immunology | ||||||
| 03/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/19/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Immunology | ||||||
| 03/15/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Immunology | ||||||
| 03/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Gastroenterology | ||||||
| 03/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 222 | 267 | $57,472 | $17,132 |
| 2022 | 5 | 203 | 249 | $46,875 | $15,514 |
| 2021 | 5 | 226 | 269 | $48,956 | $18,191 |
| 2020 | 3 | 184 | 203 | $40,172 | $11,244 |
Total Patients
835
Total Services
988
Medicare Billing
$62,081
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 144 | $34,992 | $10,247 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 61 | $10,492 | $3,299 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,452 | $1,321 | 29.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,144 | $1,302 | 31.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 32 | $3,392 | $962.85 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 128 | $27,291 | $8,992 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 66 | $9,742 | $3,500 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,016 | $1,513 | 30.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,444 | $797.86 | 32.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 27 | $2,382 | $710.65 | 29.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 126 | $25,452 | $9,807 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 78 | $10,686 | $4,123 | 38.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $8,060 | $2,655 | 32.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,626 | $834.56 | 31.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 25 | 26 | $2,132 | $771.73 | 36.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 90 | 106 | $21,520 | $6,262 | 29.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $9,610 | $2,500 | 26.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 63 | 66 | $9,042 | $2,482 | 27.4% |
About Robin Sutcliffe, APRN
Robin Sutcliffe, APRN is a Nurse Practitioner healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1730490921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robin Sutcliffe, APRN has received a total of $8,003 in payments from pharmaceutical and medical device companies, with $1,156 received in 2024. These payments were reported across 442 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,975).
As a Medicare-enrolled provider, Sutcliffe has provided services to 835 Medicare beneficiaries, totaling 988 services with total Medicare billing of $62,081. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Lexington, KY
- Active Since 06/23/2010
- Last Updated 04/05/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1730490921
Products in Payments
- XIFAXAN (Drug) $1,041
- STELARA (Biological) $727.62
- ENTYVIO (Biological) $518.70
- TRULANCE (Drug) $512.03
- DUPIXENT (Biological) $494.20
- HUMIRA (Biological) $488.63
- LINZESS (Drug) $433.35
- RINVOQ (Biological) $373.43
- CREON (Drug) $274.35
- MAVYRET (Drug) $272.36
- VOQUEZNA (Drug) $261.04
- ZENPEP (Drug) $230.66
- SKYRIZI (Biological) $193.14
- OCALIVA (Drug) $185.51
- ZEPOSIA (Drug) $184.42
- SUTAB (Drug) $138.68
- RELISTOR (Drug) $127.80
- MOTEGRITY (Drug) $125.00
- Ozempic (Drug) $125.00
- Sucraid (Drug) $122.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lexington
Rachael Bradford, Aprn, APRN
Nurse Practitioner — Payments: $369,931
Nurse Practitioner $369,931
Jessica Schorck, Aprn, APRN
Nurse Practitioner — Payments: $19,669
Nurse Practitioner $19,669
Juawanna Schuller, Arnp, ARNP
Nurse Practitioner — Payments: $19,426
Nurse Practitioner $19,426
Mrs. Megan Collett, Aprn, APRN
Nurse Practitioner — Payments: $10,839
Nurse Practitioner $10,839
Holly Chitwood, Aprn, APRN
Nurse Practitioner — Payments: $8,212
Nurse Practitioner $8,212
Bridget Shepherd Depaul, Aprn, APRN
Nurse Practitioner — Payments: $7,792
Nurse Practitioner $7,792